MoneyWorks4Me

Sun Pharma Advanced Research Company informs about press release

09 Nov 2022 Evaluate
Sun Pharma Advanced Research Company has informed that it enclosed press release, ‘SPARC and Sun Pharma enter into a license agreement for commercialization of phenobarbital for injection in the US’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 44.25
Prime Focus 279.35
Knowledge RealtyTrt. 112.60
Indegene 575.80
Syngene Internatl. 376.20
View more..